Table 5.
Incidence of adverse events
Types of organs | Aloe sterol | Placebo |
---|---|---|
Gastrointestinal abnormalities | 23 (17) | 28 (16) |
General disorders and administration site abnormalities | 4 (4) | 10 (8) |
Infections and infestations | 17 (15) | 19 (15) |
Eye abnormalities | 3 (3) | 1 (1) |
Musculoskeletal and connective tissue abnormalities | 8 (7) | 2 (2) |
Blood and lymphatic system abnormalities | 0 (0) | 2 (1) |
Respiratory, thoracic and mediastinal abnormalities | 2 (2) | 5 (5) |
Ear abnormalities | 0 (0) | 1 (1) |
Injury, poisoning and procedural complications | 1 (1) | 1 (1) |
Nervous system abnormalities | 31 (10) | 17 (11) |
Reproductive system and breast abnormalities | 0 (0) | 1 (1) |
Skin and subcutaneous tissue abnormalities | 40 (19) | 24 (12) |
Data are shown as number of cases (number of subjects).